Health

endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services

SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ -- endpoint Clinical, an industry-leading global interactive response technology (IRT) company, has appointed Christine Hurley as its Senior Vice President, Client Services.  Bringing over 20 years of experience in clinical operations and technology, Chri...

2021-02-09 22:00 5013

neoX Biotech closes US$30 million Series A round

BEIJING, Feb. 9, 2021 /PRNewswire/ -- neoX Biotech, a next-generation biotech company specializing in computational design for novel drug research and development, recently announced that it had raisedUS$30 million in Series A funding.The financing was co-led by Sky9 Capital and 5Y Capital (forme...

2021-02-09 21:28 3763

Regent Pacific's Strategic Partner Obtains Clinical Trial Approval for FORTACIN(TM)

HONG KONG, Feb. 9, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Biopharmaceutical...

2021-02-09 20:35 8439

Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China

TORONTO and SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF) today announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in theGreater China region. Nuance is a biopharmaceutical company focused on licensing, developing and com...

2021-02-09 20:00 6095

Guide IR Ranks Top 2 in Yole Report as Global Infrared Thermal Imaging Market Explodes

WUHAN, China, Feb. 9, 2021 /PRNewswire/ -- Yole Développement, the internationally renowned market survey and strategic consulting firm, has launched its latest industry analysis entitled Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary Report. The report reveals that ...

2021-02-09 19:26 3262

Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter

STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...

2021-02-09 16:30 2136

Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China

SHANGHAI, Feb. 9, 2021 /PRNewswire/ -- Yingli Pharma announced today that it reached strategic collaboration with Hengrui Medicine (600276.SH), a partnership which will significantly accelerate the expansion of Yingli Pharma's oncology business inChina, the second largest pharmaceutical market in...

2021-02-09 08:30 2343

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics

* Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiate any project within four weeks * Offer flexible large-scale manufacturing services by implementing Scale-out strategy WUXI, China, Feb. 9, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.H...

2021-02-09 08:25 2955

Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma

SAN FRANCISCO and SUZHOU, China, Feb. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2021-02-09 08:00 8996

Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development

RENO, Nev., Feb. 9, 2021 /PRNewswire/ -- Bioelectronica Corporation ("Bioelectronica") today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The ...

2021-02-09 04:46 3581

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan experts present strategic insights on key trends such as virtual care, vaccines, hospital efficiency solutions, digital biomarkers, and microbiome therapeutics SANTA CLARA, Calif., Feb. 9, 2021 /PRNewswire/ -- Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving b...

2021-02-09 01:43 309

Peloton Interactive, Inc. Announces Proposed Private Offering of $600.0 Million of Convertible Senior Notes Due 2026

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Peloton Interactive, Inc. ("Peloton") (Nasdaq: PTON) today announced its intention to offer, subject to market conditions and other factors,$600.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private offering (th...

2021-02-08 21:47 7725

Basecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF Kit

HONG KONG, Feb. 8, 2021 /PRNewswire/ -- Basecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, today officially listed on the main board of HKEX (HKG: 2170). Approximately 66.667 million shares were issued and total funds raised was...

2021-02-08 19:32 6353

Inova Appoints Claude Basset as Chief Product Officer

LYON, France, Feb. 8, 2021 /PRNewswire/ -- Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude Basset has joined their leadership team as Chief Product Officer.   Inova is a French Tech success story that, now in its 10th year, ha...

2021-02-08 16:00 1630

Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)

First Patient to Receive ORL-101 in Israel This Week BAAR, Switzerland, Feb. 8, 2021 /PRNewswire/ -- Orpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a novel ...

2021-02-08 15:00 3452

Zamst announces sponsorship with Yuji Nishida, Professional Volleyball Player

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., owner of Zamst, a brand of athletic braces and care products headquartered inTokyo, Japan, has entered a sports sponsorship agreement withYuji Nishida, Japanese men's professional volleyball player for JTEKT Stings in V.League.

2021-02-08 14:00 6170

AXA launches "Wealth Ultra Savings Plan (2-year Pay)"

HONG KONG, Feb. 8, 2021 /PRNewswire/ -- AXA Hong Kong and Macau today announced the launch of "Wealth Ultra Savings Plan (2-year Pay)"("Wealth Ultra (2-year Pay)"), a participating life insurance plan with a short premium payment term of two years. Customers can enjoy sustainable wealth growth wi...

2021-02-08 13:55 2949

iHerb officially launches an online activity named "good fortune shopping day" in the coming new year of ox

SINGAPORE, Feb. 8, 2021 /PRNewswire/ -- The year of the mouse rings out and the year of the ox rings in, and the Spring Festival of 2021 is drawing near soon. Through the epidemic haze in 2020, people value health much more and more. There's nothing better than giving our relatives and friends he...

2021-02-08 11:48 2697

Infinitus Mutual Help Organization Celebrates Its 10th Anniversary

GUANGZHOU, China, Feb. 8, 2021 /PRNewswire/ -- On January 31, 2021, a special exhibition celebrating the 10th anniversary of the founding of Infinitus Mutual Help Organization (Infinitus MHO) was held at Infinitus Xinhui Production Base in Jiangmen, Guangdong province. The goal of the six-month-l...

2021-02-08 09:00 2587

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study inJapan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin). Kyowa Kirin initiated the clinica...

2021-02-08 09:00 3655
1 ... 541542543544545546547 ... 561

Week's Top Stories